Pasar al contenido principal

PAPEL DE COX-2 EN LA COMUNICACION INTER-ORGANOS EN LA ENFERMEDAD DEL HIGADO GRASO ASOCIADO CON LA DISFUNCION METABOLICA (MAFLD): DEL RATON A SISTEMAS DE ORGAN-ON-CHIP

PID2022-143192OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Beneficial effects of hepatic cyclooxygenase-2 expression against cholestatic injury after common bile duct ligation in mice

  • Brea, Rocio
  • Casanova, Natalia
  • Álvarez-Lucena, Carlota
  • Fuertes-Agudo, Marina
  • Mebs, Dietrich
  • Luque-Tévar, María
  • Cucarella, Carme
  • Capitani, Maria C.
  • Marinochi, Maria V.
  • Fusini, Matias E.
  • Lahoz, Agustín
  • López Nogueroles, Marina
  • Fraile, Juan
  • Ronco, Maria T.
  • Boscá, Lisardo
  • González-Rodríguez, Águeda
  • García-Monzón, Carmelo
  • Martín-Sanz, Paloma
  • Casado, Marta
  • Frances, Daniel E.
15 páginas, 8 figuras, Background and aims: Cyclooxygenase-2 (COX-2) is involved in different liver diseases, but little is known about the significance of COX-2 in cholestatic injury. This study was designed to elucidate the role of COX-2 expression in hepatocytes during the pathogenesis of obstructive cholestasis. Methods: We used genetically modified mice constitutively expressing human COX-2 in hepatocytes. Transgenic mice (hCOX-2-Tg) and their wild-type (Wt) littermates were either subjected to a mid-abdominal laparotomy or common bile duct ligation (BDL) for 2 or 5 days. Then, we explored the mechanisms underlying the role of COX-2 and its derived prostaglandins in liver function, and the synthesis and excretion of bile acids (BA) in response to cholestatic liver injury. Results: After BDL, hCOX-2-Tg mice showed lower grades of hepatic necrosis and inflammation than Wt mice, in part by a reduced hepatic neutrophil recruitment associated with lower mRNA levels of pro-inflammatory cytokines. Furthermore, hCOX-2-Tg mice displayed a differential metabolic pattern of BA synthesis that led to an improved clearance after BDL-induced accumulation. In addition, an enhanced response to the BDL-induced oxidative stress and hepatic apoptosis was observed. In vitro experiments using hepatic cells that stably express hCOX-2 confirmed the cytoprotective role of prostaglandin E2 against BA toxicity. Conclusions: Taken together, our data indicate that constitutive expression of COX-2 in hepatocytes ameliorates cholestatic liver injury in mice by reducing inflammation and cell damage and by modulating BA metabolism, pointing to a role for COX-2 as a defensive response against cholestasis-derived BA accumulation and injury., This work was supported by the following projects: Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación 10.13039/501100011033 (PID2022-143192OB-I00; PID2020- 113238RB-I00), Research Grant PICT 2018-01446 and 2021-0152 from Agencia Nacional de Promoción Científica y Tecnológica (ANPCyT), iCOOP from CSIC (COOPB23081), Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CB06/04/1069), Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CB/11/00222), Consorcio de Investigación en Red de la Comunidad de Madrid, S2017/BMD-3686, and Fondo Europeo de Desarrollo Regional. C.L. and M.L-T. are both recipients of FPI fellowships from MINECO: PRE2021-097824 and PRE2020-094885, respectively. D.F. received a fellowship Ministerio de Educación de ArgentinaFundación Carolina., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Peroxynitrite is involved in the mitochondrial dysfunction induced by Sorafenib in liver cancer cells

  • Cruz-Ojeda, Patricia de la
  • Navarro-Villarán, Elena
  • Fuertes-Agudo, Marina
  • Mata, Ana
  • López-Lluch, Guillermo
  • Navas, Plácido
  • Cadenas, Susana
  • Casado, Marta
  • Muntané, Jordi
Sorafenib is a tyrosine kinase inhibitor (TKI) that belongs to the landscape of treatments for advanced stages of hepatocellular carcinoma (HCC). The induction of cell death and cell cycle arrest by Sorafenib has been associated with mitochondrial dysfunction in liver cancer cells. Our research aim was to decipher underlying oxidative and nitrosative stress induced by Sorafenib leading to mitochondrial dysfunction in liver cancer cells., We acknowledge the Instituto de Salud Carlos III (ISCIII) (PI19/01266 and PI22/00857) and Consejería de Salud y Familias (PI-0216-2020) for their financial support. Marta Casado and Marina Fuertes-Agudo were supported by Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación 10.13039/501100011033 (PID2022-143192OB-I00; RED2022-134927-T). Susana Cadenas' lab is funded by the ISCIII grant PI23/01846 and Ana Mata is recipient of a predoctoral fellowship from the Comunidad de Madrid (PIPF-2022/SAL-GL-25516). P de la Cruz-Ojeda was supported by FPU predoctoral fellowship (FPU17/00026) and short-research stage program (EST19/01091) from Ministry of Education, Culture and Sports, and GEIVEX Mobility Fellowships 2020. Elena Navarro-Villarán was supported by the predoctoral i-PFIS IIS-enterprise contract in science and technologies in health (IFI18/00014) granted by the ISCIII. We thank the Biomedical Research Network Center for Liver and Digestive Diseases (CIBEREHD) and for Rare Diseases (CIBERER) founded by the ISCIII and co-financed by European Development Regional Fund “A way to achieve Europe” ERDF for their financial support., Peer reviewed